Read More 1 minute read Analyst Ratings Initiation News Price Target RBC Capital Initiates Coverage On D2L with Outperform Rating, Announces Price Target of C$9 By Benzinga Newsdesk September 13, 5:19 AM RBC Capital analyst Maxim Matushansky initiates coverage on D2L (TSX:DTOL) with a Outperform rating and announces Price Target of C$9. TSX:DTOL
Read More 1 minute read Analyst Ratings Initiation News Price Target Truist Securities Initiates Coverage On Inari Medical with Hold Rating, Announces Price Target of $87 By Benzinga Newsdesk September 13, 5:16 AM Truist Securities analyst Richard Newitter initiates coverage on Inari Medical (NASDAQ:NARI) with a Hold rating and announces Price Target of $87. NARI
Read More 1 minute read Analyst Ratings Initiation News Price Target RBC Capital Initiates Coverage On CNO Finl Group with Outperform Rating, Announces Price Target of $25 By Benzinga Newsdesk September 13, 5:13 AM RBC Capital analyst Mark Dwelle initiates coverage on CNO Finl Group (NYSE:CNO) with a Outperform rating and announces Price Target of $25. CNO
Read More 4 minute read Analyst Color Analyst Ratings Commodities Cryptocurrency Initiation Markets Price Target Trading Ideas Gold Stocks, Bitcoin Crushed Despite Inflation Hedge Argument: Goldman Sachs Now Says Buy This Miner By Melanie Schaffer September 12, 2:36 PM Gold and Bitcoin (CRYPTO: BTC) have proven neither holds the title of being a hedge against inflation this year. AEM
Read More 1 minute read Analyst Ratings Biotech General Health Care Initiation Movers News Trading Ideas Analyst Outlines Doubts On This NASH-Focused Stock, Builds Neutral Case By Vandana Singh September 12, 2:24 PM HC Wainwright initiated Terns Pharmaceutical Inc (NASDAQ:TERN) with a Neutral rating and a price target of $6.00. The biopharmaceutical company has a… TERN
Read More 1 minute read Analyst Ratings Biotech General Health Care Initiation Movers News Price Target Trading Ideas This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says By Vandana Singh September 12, 2:21 PM HC Wainwright initiated coverage on Rain Therapeutics Inc (NASDAQ:RAIN), with a price target of $10 with a Buy rating. With an upside… DSNKY
Read More 1 minute read Analyst Ratings Initiation Movers Price Target Trading Ideas Why Lucid Stock Is Racing Higher Today By Adam Eckert September 12, 1:13 PM Lucid Group Inc (NASDAQ: LCID) shares are trading higher Monday following positive analyst coverage from RF Lafferty. LCID
Read More 1 minute read Analyst Color Analyst Ratings Initiation Too Many Subscriptions? Here’s Why An Analyst Is A Buyer Of The Trend To Cut Bills By Priya Nigam September 12, 12:04 PM Bill.com Holdings Inc (NYSE: BILL) has a first-mover advantage in accounts payable (AP) and accounts receivable (AR) automation for small and mid-sized businesses (SMBs), according to Morgan Stanley. BILL
Read More 1 minute read Analyst Ratings Initiation News Price Target RF Lafferty Initiates Coverage On Lucid Gr with Buy Rating, Announces Price Target of $19 By Benzinga Newsdesk September 12, 9:38 AM RF Lafferty analyst Jaime Perez initiates coverage on Lucid Gr (NASDAQ:LCID) with a Buy rating and announces Price Target of $19. LCID
Read More 1 minute read Analyst Ratings Cannabis Initiation Markets News Price Target Goldman Sachs Initiates Coverage On Wheaton Precious Metals with Buy Rating, Announces Price Target of C$53 By Benzinga Newsdesk September 12, 7:26 AM Goldman Sachs analyst Emily Chieng initiates coverage on Wheaton Precious Metals (TSX:WPM) with a Buy rating and announces Price Target of C$53. TSX:WPM